Compare Smith & Nephew plc (SNN) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Victoria's Secret & Co — how do they compare? Smith & Nephew plc trades at $27.08 (market cap $11.10B), while Victoria's Secret & Co trades at $82.43 (market cap $6.91B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Smith & Nephew plc pays a 2.95% dividend while Victoria's Secret & Co pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 120 Days and Victoria's Secret & Co for 34 Days on average.
| SNN | VSXY | |
|---|---|---|
Market Cap | $11.10B | $6.91B |
Volume | 1,051,703 | 1,346,928 |
Sector | Health | Consumer Cyclical |
52-Week High | $37.17 | $99.97 |
52-Week Low | $26.42 | $28.25 |
Typical Hold Time | 120 Days | 34 Days |
Enterprise Value | $14.13B | $9.29B |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue and net income have grown steadily, reaching $6.16B and $625M in 2025, respectively, with improving margins. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. However, cash flow volatility and mixed analyst sentiment pose challenges.
The stock presents a value opportunity with reasonable valuation ratios (P/E 18.34, P/S 1.85), but risks include competitive pressures and recent CFO departure. Analyst consensus is cautious, with 65% hold ratings. Upside depends on execution of growth initiatives amid market headwinds.
Victoria's Secret (VSXY) trades at $85.79, up 0.83% with a bullish technical signal and strong earnings beat history. The stock shows robust profitability with 45.27% ROE and 39.57% gross margins, though net margins remain modest at 5.47%. Recent news highlights fashion show expansion and global growth initiatives, with institutional buying supporting positive sentiment. The current price sits near the consensus target of $86.80, with support at $85 and resistance at $87.
VSXY presents a compelling growth story with accelerating fundamentals and analyst support, though rich valuation at 19.33 P/E and competitive retail pressures warrant caution. The 2026 outlook improvement and consistent earnings beats provide upside potential, while margin pressures and consumer spending volatility represent key risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
